The Next Step In Human Evolution Worth $25 Billion By 2030


CRISPR presents an opportunity to major organizations of using the convergence of biology and technology to improve human life at large

Like most scientific revolutions, this has also produced several pros and cons, with the pros thus far seeming to outweigh the cons. While the growth potential here is immense, the ethical considerations need be settled by legal and regulatory authorities. They should come up with guidelines for managing the interests of both human life and major organizations, and avoid any possible large-scale negative implications for future generations. In most countries, there are currently no guidelines on genetic modification in human reproduction. Those who do have such guidelines have only banned such activities (especially in Europe). Even the medical research community has not supported the idea of modifying embryos. However they are highly optimistic about the applications for rare and genetic diseases. Thus the larger picture has to be looked at, while taking such decisions on the basis of ethical considerations.

At the moment, the sector seems an exciting one, with numerous developments happening across the value chain. It will be interesting to see how different stakeholders take up different opportunities and challenges, as these come their way!

Read More at Forbes

Read the rest at Forbes